Page last updated: 2024-08-22

tricalcium phosphate and Coronary Restenosis

tricalcium phosphate has been researched along with Coronary Restenosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bianchi, CF; Buchholz, B; Gao, F; Gu, Z; Laham, R; Ma, X; McCarthy, S; Oyamada, S; Robich, MP; Sellke, FW; Wang, X; Wu, H; Wu, T	1
Chen, J; Feng, G; Huo, Z; Jiang, X; Kang, G; Kislauskis, E; Laham, R; Lan, Z; Liao, T; McCarthy, S; Wang, Q; Wang, Z; Wu, T; Xi, T; Xia, J; Xiao, J	1

Other Studies

2 other study(ies) available for tricalcium phosphate and Coronary Restenosis

Article	Year
Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies. Journal of pharmaceutical and biomedical analysis, 2011, Mar-25, Volume: 54, Issue:4 Topics: Animals; Antineoplastic Agents; Aorta, Abdominal; Calcium Phosphates; Coronary Artery Disease; Coronary Restenosis; Drug Combinations; Drug-Eluting Stents; Kinetics; Lactic Acid; Male; Microscopy, Electron, Scanning; Paclitaxel; Pilot Projects; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Sirolimus; Solubility; Surface Properties; Tubulin Modulators	2011
6-Month Follow-Up of a Novel Biodegradable Drug-Eluting Stent Composed of Poly-L-Lactic Acid and Amorphous Calcium Phosphate Nanoparticles in Porcine Coronary Artery. Journal of biomedical nanotechnology, 2015, Volume: 11, Issue:10 Topics: Absorbable Implants; Animals; Calcium Phosphates; Coronary Restenosis; Coronary Vessels; Drug Implants; Drug-Eluting Stents; Follow-Up Studies; Lactic Acid; Longitudinal Studies; Materials Testing; Nanocapsules; Paclitaxel; Polyesters; Polymers; Swine	2015

Article

Year

Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.

Journal of pharmaceutical and biomedical analysis, 2011, Mar-25, Volume: 54, Issue:4

Topics: Animals; Antineoplastic Agents; Aorta, Abdominal; Calcium Phosphates; Coronary Artery Disease; Coronary Restenosis; Drug Combinations; Drug-Eluting Stents; Kinetics; Lactic Acid; Male; Microscopy, Electron, Scanning; Paclitaxel; Pilot Projects; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Sirolimus; Solubility; Surface Properties; Tubulin Modulators

2011

6-Month Follow-Up of a Novel Biodegradable Drug-Eluting Stent Composed of Poly-L-Lactic Acid and Amorphous Calcium Phosphate Nanoparticles in Porcine Coronary Artery.

Journal of biomedical nanotechnology, 2015, Volume: 11, Issue:10

Topics: Absorbable Implants; Animals; Calcium Phosphates; Coronary Restenosis; Coronary Vessels; Drug Implants; Drug-Eluting Stents; Follow-Up Studies; Lactic Acid; Longitudinal Studies; Materials Testing; Nanocapsules; Paclitaxel; Polyesters; Polymers; Swine

2015